#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Dementia Alzheimer's type Rhabdomyosarcoma Emphysema Osteogenesis imperfecta Angiosarcoma metastatic Asthma Phenylketonuria Giant cell tumour of tendon sheath Loss of consciousness Infantile apnoea Brain stem glioma Pulmonary sarcoidosis Glomerulonephritis minimal lesion Methylmalonic acidaemia Myotonic dystrophy More trials…

    Learn about Rare Diseases

    VEXAS syndrome – Life with Disease Andersen-Tawil syndrome – Trials in Disease Idiopathic inflammatory myopathy – Trials in Disease Arterial tortuosity syndrome – Life with Disease Systemic sclerosis pulmonary – Life with Disease Hairy cell leukaemia recurrent – Diagnostics Usher’s syndrome – Basic Information Immunodeficiency congenital – Life with Disease Behcet’s syndrome – Life with Disease Marfan’s syndrome – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Metolazone Cetuximab Melatonin Nemtabrutinib Benztropine Mesylate BGB-16673 Tetrahydrouridine VG801-1 Antiemetics And Antinauseants Setanaxib Octreotide Acetate Tilsotolimod Sodium Ublituximab Nilutamide Amisulpride Hct116-B Dextrose Bp Treprostinil Palmitil Lenalidomide Abc-15A-116 More therapies…

    Learn about Your Condition

    Choroidal neovascularisation Actinic cheilitis Anaemia of chronic disease Tubulointerstitial nephritis Septic shock Hysterectomy Chondropathy Neurotrophic keratopathy Mucopolysaccharidosis Colon cancer stage IV Malignant melanoma stage IV Solitary fibrous tumour Deafness Angelman's syndrome Follicular lymphoma stage IV More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Azienda Usl Toscana Nord Ovest-Ospedale Civile di Livorno…

Azienda Usl Toscana Nord Ovest-Ospedale Civile di Livorno

Viale Alfieri n. 36, Leghorn, Italy

Want to learn more about this study or check if you can participate? Contact us.

  • Study of Axitinib and Nivolumab for Patients with Metastatic Renal Cell Carcinoma Not Responding Completely to Initial Treatment

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Metastatic renal cell carcinoma
    Investigated Drugs:
    • Axitinib
    Italy Spain
  • Study comparing cetuximab with chemotherapy versus bevacizumab with chemotherapy in patients with advanced colorectal cancer who have wild-type RAS and right-sided tumors

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Colorectal cancer
    Investigated Drugs:
    • Bevacizumab
    • Capecitabine
    • Cetuximab
    Germany Italy Spain

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.

Numer nieprawidłowy!
Numer nieprawidłowy!